Frontier Medicines: Funding, Investors & Team (Oct 2026)
Frontier Medicines is a biopharmaceutical company utilizing a chemoproteomics platform to expedite the creation of medications. This platform incorporates sophisticated computational methods and machine learning to identify and target novel binding sites on proteins, enabling easier development of small-molecule drugs.
Frontier Medicines has raised $189M across 3 funding rounds on record, the most recent a Series C of $20.0M announced in Jun 2024.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Frontier Medicines Company Profile and Key Stats
Latest funding round on record: Jun 2024.
Frontier Medicines Funding Rounds
Frontier Medicines raised $88.5M in a Series B announced in Jul 2021.
2.6 years later, a Series C of $80.0M was announced in Feb 2024.
4 months later, a Series C of $20.0M was announced in Jun 2024.
Frontier Medicines Founders and Leadership Team
Contact details for the Frontier Medicines team: 1 of 1 has an email address on file.
Start 14-day free trial →Frontier Medicines Funding Compared to Other Biotechnology Startups
Frontier Medicines' latest round of $20.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Frontier Medicines in Biotechnology and San Francisco
Companies Similar to Frontier Medicines
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Frontier Medicines Funding FAQs
What does Frontier Medicines do?
Frontier Medicines is a biopharmaceutical company utilizing a chemoproteomics platform to expedite the creation of medications. This platform incorporates sophisticated computational methods and machine learning to identify and target novel binding sites on proteins, enabling easier development of small-molecule drugs.
How much funding has Frontier Medicines raised?
Frontier Medicines has raised $189M across 3 rounds on record. The most recent is a Series C of $20.0M announced in Jun 2024.
When did Frontier Medicines last raise funding?
Frontier Medicines' most recent funding round on record is a Series C of $20.0M, announced in Jun 2024.
Who founded Frontier Medicines?
FundedIQ lists Chris Varma (Founder) at Frontier Medicines.
Where is Frontier Medicines headquartered?
Frontier Medicines is based in San Francisco, California, United States.
How many employees does Frontier Medicines have?
Frontier Medicines is in the 101-250 employee band.
How does Frontier Medicines' funding compare to other Biotechnology startups?
Frontier Medicines' latest round of $20.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Frontier Medicines Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Frontier Medicines is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.